Biomaterial Database

[Anemia and hormone therapy for patients on intermittent chronic hemodialysis]. 1974

H Matsuoka, and T Tamura

UI	MeSH Term	Description	Entries
D007676	Kidney Failure, Chronic	The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D005260	Female		Females
D006435	Renal Dialysis	Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.	Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D000728	Androgens	Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.	Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D000740	Anemia	A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.	Anemias

Related Publications

H Matsuoka, and T Tamura

Survival data for patients undergoing chronic intermittent hemodialysis.

February 1969, Annals of internal medicine,

H Matsuoka, and T Tamura

[Iron therapy in patients in the chronic intermittent hemodialysis program (CHIHP)].

January 1981, Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum,

H Matsuoka, and T Tamura

FECAL POTASSIUM EXCRETION IN PATIENTS ON CHRONIC INTERMITTENT HEMODIALYSIS.

January 1965, Transactions - American Society for Artificial Internal Organs,

H Matsuoka, and T Tamura

[Parenteral iron substitution for the therapy of anemia in patients under chronic hemodialysis].

June 1973, Die Medizinische Welt,

H Matsuoka, and T Tamura

2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.

December 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy,

H Matsuoka, and T Tamura

[The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].

January 1990, Urologiia i nefrologiia,

H Matsuoka, and T Tamura

Intermittent hemodialysis for chronic renal failure.

March 1967, The Journal of urology,

H Matsuoka, and T Tamura

[Parathyroid function in patients on chronic intermittent hemodialysis (author's transl)].

August 1977, Klinische Wochenschrift,

H Matsuoka, and T Tamura

Anemia in patients on maintenance hemodialysis: the effect of parathyroid hormone.

January 1986, Acta medica Iugoslavica,